SWITCHING THERAPY TO FINGOLIMOD IMPROVES CLINICAL AND MRI OUTCOMES

Eli Silber; L Kappos; EW Radue; P Connor; M Amato; L Zhang-Auberson; D Haering; G Francis

doi:10.1136/jnnp-2014-309236.147

Article info

PDF

ABN Abstracts

Abstracts

147

SWITCHING THERAPY TO FINGOLIMOD IMPROVES CLINICAL AND MRI OUTCOMES

Free

Authors

Eli Silber King's College Hospital, London PubMed articles Google scholar articles
L Kappos Neurology and Department of Biomedicine University Hospital Basel PubMed articles Google scholar articles
EW Radue University Hospital Basel PubMed articles Google scholar articles
P Connor St. Michael's Hospital, Canada PubMed articles Google scholar articles
M Amato University of Florence, Italy PubMed articles Google scholar articles
L Zhang-Auberson Novartis Pharma AG, Basel PubMed articles Google scholar articles
D Haering Novartis Pharma AG, Basel PubMed articles Google scholar articles
G Francis Novartis Pharmaceuticals Corporation, USA PubMed articles Google scholar articles

Citation

Silber E, Kappos L, Radue E, et al

SWITCHING THERAPY TO FINGOLIMOD IMPROVES CLINICAL AND MRI OUTCOMES

Journal of Neurology, Neurosurgery & Psychiatry 2014;85:e4.

Publication history

First published September 9, 2014.

Online issue publication

April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password